1. Home
  2. ESP vs RVPH Comparison

ESP vs RVPH Comparison

Compare ESP & RVPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ESP
  • RVPH
  • Stock Information
  • Founded
  • ESP 1928
  • RVPH 2006
  • Country
  • ESP United States
  • RVPH United States
  • Employees
  • ESP N/A
  • RVPH N/A
  • Industry
  • ESP Industrial Machinery/Components
  • RVPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • ESP Technology
  • RVPH Health Care
  • Exchange
  • ESP Nasdaq
  • RVPH Nasdaq
  • Market Cap
  • ESP 84.1M
  • RVPH 88.0M
  • IPO Year
  • ESP N/A
  • RVPH N/A
  • Fundamental
  • Price
  • ESP $28.49
  • RVPH $2.09
  • Analyst Decision
  • ESP
  • RVPH Strong Buy
  • Analyst Count
  • ESP 0
  • RVPH 5
  • Target Price
  • ESP N/A
  • RVPH $11.40
  • AVG Volume (30 Days)
  • ESP 8.0K
  • RVPH 1.8M
  • Earning Date
  • ESP 02-18-2025
  • RVPH 11-14-2024
  • Dividend Yield
  • ESP 3.05%
  • RVPH N/A
  • EPS Growth
  • ESP 51.69
  • RVPH N/A
  • EPS
  • ESP 2.46
  • RVPH N/A
  • Revenue
  • ESP $40,611,323.00
  • RVPH N/A
  • Revenue This Year
  • ESP N/A
  • RVPH N/A
  • Revenue Next Year
  • ESP N/A
  • RVPH N/A
  • P/E Ratio
  • ESP $11.69
  • RVPH N/A
  • Revenue Growth
  • ESP 14.32
  • RVPH N/A
  • 52 Week Low
  • ESP $20.20
  • RVPH $0.60
  • 52 Week High
  • ESP $33.00
  • RVPH $4.83
  • Technical
  • Relative Strength Index (RSI)
  • ESP 47.88
  • RVPH 60.41
  • Support Level
  • ESP $27.68
  • RVPH $1.78
  • Resistance Level
  • ESP $29.30
  • RVPH $2.15
  • Average True Range (ATR)
  • ESP 0.70
  • RVPH 0.15
  • MACD
  • ESP 0.01
  • RVPH 0.02
  • Stochastic Oscillator
  • ESP 45.76
  • RVPH 88.30

About ESP Espey Mfg. & Electronics Corp.

Espey Manufacturing & Electronics Corp designs, develops, tests, and manufactures specialized military and rugged industrial power supplies and transformers for use in harsh or severe environment applications. Its products and solutions include power converters, power conditioning, high-voltage radar, contract manufacturing, custom engineering, and others. The applications of these products include AC and DC locomotives, shipboard power, shipboard radar, airborne power, ground-based radar, and ground mobile power.

About RVPH Reviva Pharmaceuticals Holdings Inc.

Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, and Parkinson's disease psychosis and its other drug candidate is RP1208.

Share on Social Networks: